Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies-Reference-Cited by-同舟云学术

Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies

Published:2000-10 Issue:10 Volume:11 Page:1313-1322
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ochoa L.,Hurwitz H.I.,Wilding G.,Cohen D.,Thomas J.P.,Schwartz G.,Monroe P.,Petros W.P.,Ertel V.Ph.,Hsieh A.,Hoffman C.,Drengler R.,Magnum S.,Rowinsky E.K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/10/1313/19477905/11-10-1313.pdf

Reference26 articles.

1. Fluorouracil in colorectal cancer – a tale of two drugs: Implications for biochemical modulation;Sobrero;J Clin Oncol,1997

2. Hepatic arterial chemotherapy for metastatic colorectal carcinoma;de Takats;Br J Cancer,1994

3. Clinical pharmacology of 5-fluorouracil;Diasio;Clin Pharmacokin,1989

4. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group study;Leichman;J Clin Oncol,1995

5. Meta-analysis of all trials comparing intraveous bolus administration to continuous infusion of 5-fluorouracil in patients will advanced colorectal cancer;Rougier;Proc Am Soc Clin Oncol,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral drugs in the treatment of metastatic colorectal cancer;Therapeutic Advances in Medical Oncology;2021-01

2. Eniluracil Plus 5-Fluorouracil and Leucovorin: Treatment for Metastatic Breast Cancer Patients in Whom Capecitabine Treatment Rapidly Failed;Clinical Breast Cancer;2014-02

3. Predicting concentrations of the cytostatic drugs cyclophosphamide, carboplatin, 5-fluorouracil, and capecitabine throughout the sewage effluents and surface waters of europe;Environmental Toxicology and Chemistry;2013-07-26

4. Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement;Clinical Pharmacokinetics;2013-02-19

5. Development and utilization of a combined LC–UV and LC–MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin;Journal of Chromatography B;2012-06